Welcome to the June edition of BioMatrix Abstract!
BioMatrix Specialty Infusion Pharmacy
BioMatrix is a trusted specialty pharmacy to patients, prescribers, pharmaceutical manufacturers and payers nationwide.
BioMatrix Abstract informs readers of our leading efforts in the specialty infusion pharmacy space while providing updates on relevant legislative efforts, research initiatives, and current events in healthcare.
DISCLAIMER: THIS IS NOT MEDICAL OR LEGAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider or as legal advice. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.
Distinguishing CIDP Symptoms from GBS
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Guillain-Barré syndrome (GBS) are autoimmune disorders that lead to nerve damage and impaired function. Here's some key differences in their symptoms.
Pickleball for a Purpose: Supporting the Myasthenia Gravis Association (MGA) in Kansas City
Check out some photos of our Pickleball for a Purpose event with the Myasthenia Gravis Association (MGA). What a fun time and a great turnout—thank you to all who participated! MGA is dedicated to supporting individuals, families, friends, and communities impacted by myasthenia gravis. They serve a large part of the Midwest (with a national virtual presence) for patient advocacy and support groups.
Polymyositis and Dermatomyositis: Signs, Symptoms, and Treatment Options
Myositis is a group of rare autoimmune diseases characterized by chronic inflammation and damage to the skeletal muscles. Among the different types of myositis, polymyositis and dermatomyositis are two of the most common forms.
Interested in Getting Started with BioMatrix?
I am a Patient
Throughout every step of your treatment journey, we are committed to your success. Whether you're looking for infusion medication, infusion nursing, or have questions about your insurance, we're here to help.
I am a Provider
From prescription intake through insurance authorization, medication delivery, and nursing services, we work with you and your team to support your patients’ success. Get started by submitting a referral.
BioMatrix on the Move!
Recommended by LinkedIn
Upcoming Events
Catch up with BioMatrix at these upcoming events. We can't wait to see you!
BioMatrix Was Proud to Attend and Support These Meetings
Thanks to all who participated!
Autoimmune Disorders
We provide specialty infusion pharmacy and support services for patients with autoimmune disorders. Immunoglobulin (IG) helps calm the immune system and reduce inflammatory flare ups associated with autoimmune disorders. Our immunology program includes a full line of specialty medications used to treat autoimmune disorders, including immunoglobulin (IG) which has become the standard treatment option in practices throughout the U.S.
BioMatrix helps manage the individual needs of patients requiring IG therapy. As a specialty infusion pharmacy, our clinical teams have extensive training and experience in rare diseases, infusion therapies, and complex medical conditions. Knowledgeable pharmacists and care coordination staff guide each patient through the potential medication side effects and, working with the prescribing physician, help manage treatment to reduce the prevalence and severity of relapses.
We also administer in-home treatment to provide a more comfortable and convenient infusion experience. The result is safe, consistent, and compassionate treatment for our patients with nursing needs. Where appropriate, our in-home nursing team trains patients to administer their own injectable or infusible drugs, fostering more independence. After the home visit and administration, our nurses also guide patients on continuing with their therapy, help minimize or manage side effects, and answer questions that patients may have throughout their treatment plan.
340B
After hearing testimony from 340B partners, Congress appears to side more with pharmaceutical manufacturers than hospitals in the debate. Congress agrees to the program needing more oversight and has pushed forward a bill, “340B Access Act,” that would restrict contract pharmacies and would require hospitals to report how they use their savings. On the other side, the “340B Patients Act” would penalize drugmakers who impose contract pharmacy restrictions. In a recent court win, however, drug manufacturers are being allowed to impose restrictions on contract pharmacies.
Nursing
The nursing debate continues: do we have a nursing shortage, or not? Hospitals report a shortage, but other sources counter this. For one, there was a 6% increase in registered nurses in 2023, but that growth occurred in non-hospital settings. Some sources allege hospitals keep nursing staff short as a means to control costs; others claim nurses have soured on parts of the industry with poor working conditions.
Thanks for being a part of our inaugural pickleball event!